Ovid Therapeutics Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| (NASDAQ: OVID) | Delayed: 2.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.37 | 52 Week High | $ | |||
| Open | $2.36 | 52 Week Low | $ | |||
| Day High | $2.38 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $ | |||
| Volume | 48,715 | |||||
| (NASDAQ: OVID) | Delayed: 2.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.37 | 52 Week High | $ | |||
| Open | $2.36 | 52 Week Low | $ | |||
| Day High | $2.38 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $ | |||
| Volume | 48,715 | |||||
